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Abstract 
In order to develop a minimalist chemical model of matrix metalloproteinases (MMPs), we 
synthesized a pentadecapeptide (Ac-KAHEFGHSLGLDHSK-NH2) corresponding to the 
catalytic zinc(II) binding site of human MMP-13. The multi-domain structural organization of 
MMPs fundamentally determines their metal binding affinity, catalytic activity and 
selectivity. Our potentiometric, UV-VIS, CD, EPR, NMR, ESI-MS and kinetic study are 
aimed to explore the usefulness of flexible peptides to mimic the more rigid metal binding 
sites of proteins, to examine the intrinsic metal binding properties of this naked sequence, as 
well as to contribute the development of a minimalist, peptide-based chemical model of 
MMPs, including the catalytic properties. Since multiimidazole environment is also 
characteristic for copper(II), and recently copper(II) containing variants of MMPs have been 
identified, we also studied the copper(II) complexes of the above peptide.  
Around pH 6-7 the peptide, similarly to MMPs, offers {3Nim} coordinated binding site 
for both zinc(II) and copper(II). In the case of copper(II), the formation of amide coordinated 
species at higher pH ceased the analogy with the copper(II) containing MMP variant. On the 
other hand, the zinc(II)-peptide system mimics some basic features of the MMP active sites: 
the main species around pH 7 (ZnH2L) possesses {3Nim,H2O} coordination environment, the 
deprotonation of the zinc-bound water takes place near to the physiological pH, it forms 
relatively stable ternary complexes with hydroxamic acids, and the species ZnH2L(OH) and 
ZnH2L(OH)2 have notable hydrolytic activity between pH 7-9.  
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Introduction 
The metal binding side chains in metalloproteins are generally far-away from each other in 
the primary sequences, they are often separated by more than hundred amino acids. Such 
metal binding sites are obviously difficult to mimic by small peptides. However, a number of 
proteins possess relatively short histidine-rich sequences with strong metal binding ability, 
which substantially contributes to the function of the given macromolecule [1-18]. Beside the 
well known human serum albumin (HSA) [1], probably the prion proteins (PrP) [2] are the 
most studied examples of such sequences. Studies on the metal ion binding of peptides related 
to the N-terminal of HSA [3-5], and those mimicking the octarepeat region of PrP [6-8] 
demonstrated the usefulness of such studies. Besides, several peptides copying the putative 
metal binding sequences of e.g. human α-synuclein [9], human endostatin [10], bacterial 
superoxide dismutases [11,12] and E. coli SlyD protein [13] have been studied to uncover fine 
functional details of the corresponding proteins. However, these metal binding sequences are 
part of less structured regions, frequently at the N-terminals, which may allow closer analogy 
in the metal binding properties of model peptides and native proteins.  
Sequences within the polypeptide chains are generally more rigid due to the tertiary structure 
of the proteins, which provides preorganized binding site for the metal ion(s) in 
metalloproteins. In spite of the short sequences, such preorganization obviously reduces the 
analogy with a more flexible oligopeptides. Nevertheless, a number of studies are reported in 
the literature dealing with short in-chain sequences as putative metal binding sites of e.g. 
amyloid precursor protein [14], the repeat sequences of Cap43 [15] and histidine-rich 
(glyco)proteins [16], the histon H2A protein [17] or the metal-transport protein IRT1 [18]. In 
spite of the limited analogy between such peptides and the native proteins, in the absence of 
structural information such studies are of great values, since even the identification of putative 
metal binding sites may improve our knowledge on the functioning of the given proteins.     
In this context it would be interesting to examine such peptide-protein analogy from a reverse 
point of view, i.e. studying a relatively short, flexible peptide corresponding to the metal 
binding site of a structurally well characterized metalloprotein. In this way one would explore 
the usefulness of peptides, lacking the structural stabilization determined by the tertiary 
structure, to mimic preorganized metal binding sites of proteins. For this end, the consensus 
catalytic metal binding sequence of matrix metalloproteinases (MMPs) is well suited. These 
enzymes are responsible for remodelling of connective tissues, and are essential for e.g. 
embryonic development, cell growth, proliferation, and wound repair. MMPs are also 
implicated in a number of pathological processes, such as arthritis, cardiovascular and 
neurological diseases, tumour cell invasion and metastasis. Consequently, these enzymes are 
important therapeutic targets for the treatment of the above diseases [19]. Matrix 
metalloproteinases contain two zinc ions, one has catalytic the other has structural role. The 
N-terminally located catalytic domain of MMPs are characterized by a well conserved 
sequence with a histidine-triad (HExxHxxGxxH) which coordinates the catalytic zinc ion and 
contains the glutamate residue that is also critical for catalysis. The catalytic zinc is 
coordinated by three imidazole nitrogens and a water molecule [20].  
In this study we report the coordination properties of a pentadecapeptide (Ac-
KAHEFGHSLGLDHSK-NH2, L) corresponding to the catalytic zinc(II) binding site (197-
213) of human MMP-13 [21], except the first position where the valine has been replaced by 
lysine in order to increase the water solubility of the peptide and its metal complexes. Our 
potentiometric, UV-VIS, CD, EPR, NMR, ESI-MS and kinetic study are aimed to explore the 
intrinsic properties of this naked, virtually unstructured metal binding sequence, as well as to 
contribute the development of a minimalist, peptide-based chemical model of MMPs, 
including the catalytic properties and the binding to hydroxamic acids, as model of MMP 
inhibitors [22]. Since the multiimidazole environment is also characteristic for copper(II), and 
recently copper(II) containing variants of MMPs have been identified in Volvox carteri [23], 
for comparative purposes we also studied the copper(II) complexes of the peptide.  
 
2. Materials and methods 
 
Copper(II) and zinc(II) chloride solutions were prepared from analytically pure compounds 
(Fluka) and standardized complexometrically. pH-metric titrations were performed by 0.1 M 
NaOH (Fluka) standard solution. Fmoc-amino acids, 2-(1H-benzotriazole-1-yl)-1,1,3,3-
tetramethyluronium hexafluorophosphate (HBTU) and N-hydroxybenzotriazole (HOBt) were 
purchased from Novabiochem. N,N-diisopropylethylamine (DiPEA), diethylether (Sigma), 
triisopropylsilane, piperidine (Aldrich), pyridine (Merck), acetic anhydride (Fluka), 
trifluoroacetic acid (Riedel-de Haën), N,N-dimethyl-formamide (DMF), dichloromethane, 
methanol (Molar Chemicals), and acetonitrile (Scharlau) were analytically pure chemicals and 
used without further purification.  
 
2.1 Synthesis of Ac-KAHEFGHSLGLDHSK-NH2 peptide (L)  
The peptide was prepared by solid phase peptide synthesis using the Fmoc methodology 
(Fmoc = 9-fluorenylmethoxycarbonyl). Tentagel S RAM 0.25 mmol/g (Iris Biotech GmbH) 
was used as a solid support. The amino acid building blocks were applied in 4-fold excess 
over the capacity of the resin. The amino acid residues were coupled to each other (and to the 
resin) by applying HBTU (4 eq./building block), HOBt (4 eq./building block) and N,N-
diisopropylethylamine (8 eq./building block) in DMF. The Fmoc-protecting groups were 
removed by using a solution of 20% piperidine in DMF. The usual coupling reaction time was 
1 h. The attachment of each amino acid residues was monitored by Kaiser-test [24] and by the 
detection of the cleaved Fmoc group at 290 nm in DMF. In the case of successful coupling the 
free residual amino nitrogens were acetylated with the mixture of acetic anhydride, 
dichloromethane and diisopropylethylamine (10–80–10%). After the last coupling step the 
resin was rinsed by dichloromethane and methanol, and then it has been dried. Cleavage of 
the peptide from the resin was performed in the mixture of TFA, H2O and triisopropylsilane 
(95–2.5–2.5%). The peptide was preciptated with diethyl ether, re-dissolved in water and 
freeze-dried. The crude product was purified by RP-HPLC (Shimadzu LC-20) using a 
Supelco Discovery BIO Wide Pore C18 (250×10 mm, 5 µm) semi preparative column. The 
compound was eluted by using the mixtures of water containing 0.1% TFA and acetonitrile 
(Eluent A: 99.9% H2O, 0.1% TFA, Eluent B: 99.9% CH3CN, 0.1% TFA) with a 3 mL/min 
flow rate and applying the following gradient program: 0-5 min 12 % B; 5-17 min 12-14 % B 
(linear gradient); 17-25 min 14-18 % B (linear gradient); 25-40 min 18-70 % B (linear 
gradient); 40-45 min 70-12 % B (linear gradient); (Rt = 13.4 min). After purification the 
ligand was obtained as a trifluoroacetate salt, the yield was 53.0%. The HPLC chromatogram 
of the purified peptide is depicted in Fig. S1 (see Supplementary Data). 
The peptide was identified by ESI-MS: m/z = 852.45 [M + 2H]2+ and m/z = 568.63 [M + 
3H]3+. The calculated monoisotopic molecular mass is: 1702.85 Da. The purity was also 
confirmed by potentiometry and NMR spectroscopy. 
 
2.2 Potentiometric measurements  
The protonation and coordination equilibria were investigated by potentiometric titrations in 
aqueous solution (I = 0.1 M NaCl, and T = 298.0 ± 0.1 K) under argon atmosphere, using an 
automatic titration set including a PC controlled Dosimat 665 (Metrohm) autoburette and an 
Orion 710A precision digital pH-meter. The Metrohm Micro pH glass electrode (125 mm) 
was calibrated [25] via the modified Nernst equation: 
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where JH and JOH are fitting parameters in acidic and alkaline media for the correction of 
experimental errors, mainly due to the liquid junction and to the alkaline and acidic errors of 
the glass electrode; Kw = 10–13.75 M2 is the autoprotolysis constant of water at 298 K [26]. The 
parameters were calculated by the non-linear least squares method. The complex formation 
was characterized by the following general equilibrium process: 
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where M denotes the metal ion and L and B the non-protonated peptide and benzohydroxamic 
acid molecules, respectively. Charges are omitted for simplicity, but can be easily calculated 
taking into account the composition of the fully protonated ligands (H7L5+ and HB). The 
corresponding formation constants (βMpHqLrBs ≡ βpqrs) were calculated using the PSEQUAD 
computer program [27]. 
 The protonation constants were determined from 4 independent titrations (90 data points 
per titration), with peptide concentration 1-1.5×10–3 M. The complex formation constants 
were evaluated from 7 and 9 independent titrations (70-90 data points per titration) in case of 
the zinc(II) and copper(II) containing systems, respectively. The metal-to-ligand ratios were 
2:1, 1:1 and 1:2 (in case of zinc(II) precipitation occurred above pH 7 at twofold metal ion 
excess). The metal ion concentrations varied between 0.6-2.9×10–3 M. The titrations were 
performed between pH 2.6 and 11.4, but due to the rather low concentrations of the peptide (–
log cpeptide= 2.5 – 3.2), the derived equilibrium data of the processes below pH 3.6 and above 
pH 10.4 have increased uncertainties.   
 
2.3 Electronic absorption and CD measurement 
UV-Vis spectra were measured on a Unicam Helios α spectrophotometer using a cell with 1 
cm optical pathlength. The CD spectra were recorded on a Jasco J-710 spectropolarimeter in 
the wavelength interval from 300 to 800 nm in a cell with 1 cm optical pathlength. The metal 
ion concentration was varied between 0.8-2.8×10–3 M, depending on the metal-to-ligand ratio. 
For the copper(II) containing systems the pH-dependent UV-Vis spectra were treated together 
with pH-potentiometric data using the computer program PSEQUAD [27], resulting the 
formation constants (βpqr) and the individual UV-Vis spectra of the copper(II) complexes. The 
individual CD spectra were also calculated by PSEQUAD. 
 
2.4 EPR and NMR measurements  
The EPR spectra were recorded at 77 K using a BRUKER EleXsys E500 spectrometer. All 
recorded EPR spectra in the systems were simulated with a spectrum decomposition method 
by a computer program [28]. Since the copper(II) salt used to make the stock solution was a 
natural mixture of the isotopes, the spectrum of each species was calculated as the sum of 
spectra containing 63Cu and 65Cu weighted by their abundances in nature. The copper and 
ligand coupling constants are given in units of gauss (1 G = 10–4 T).  
1H NMR measurements were performed on a Bruker Avance DRX 500 spectrometer. The 
spectra were recorded at 25 °C in 100% D2O solution, at a peptide concentration of 3.0–
6.0×10–3 M (the tube diameter was 5 mm). The pH was adjusted to the desired values with 
NaOD.  2D COSY, TOCSY and ROESY spectra were acquired with 2048(F2)×1024(F1) 
complex points. The TOCSY experiments employed the MLEV17 sequence with a mixing 
time of 75 ms. ROESY spectra were acquired with mixing times of 300 ms. The chemical 
shifts δ were measured with respect to dioxane as internal reference and converted relative to 
SiMe4, using δdioxane = 3.70. Data were processed using the Topspin 2.0 software package 
(Bruker). 
 2.5 Mass spectrometric measurements  
Mass spectrometry was performed on a Waters Micromass(R) Q-TOF Premier mass 
spectrometer operating in negative and positive mode using electrospray source (ESI). The 
samples were dissolved in methanol(90%)-water(10%) mixture and transferred into a mass 
spectrometer by direct infusion at a flow rate of 10 µl/min. The capillary and cone voltages 
were set to (+,-) 3.3 kV and (+,-) 26 V. The desolvation temperature was set to 150 oC and the 
source temperature to 85 oC. The cone gas was at a flow rate of 50 L/h, whereas the 
desolvation gas flow was maintained at 200 L/h. For qualitative analysis the identified copper 
complex ions were detected in an MS survey scan of 1 s from an m/z of 50 to 1990 using 5 
eV collision energy. The TOF was calibrated on daily basis using sodium-formate solution in 
negative and positive mode and subsequently operated at high accuracy (<5 ppm) without 
utilizing reference masses. All data were acquired and theoretical isotope patterns were 
determined by MassLynx V4.1 software (Waters Inc.). 
 
2.6 Kinetic study  
The hydrolysis of p-nitrophenyl acetate (pNPA) was followed in a buffered aqueous solution 
containing 10 % CH3CN (I = 0.1 M NaCl, T = 298 K) by detecting the increase in absorption 
maximum at 400 nm of the p-nitrophenolate anion (ε=18900, pK=6.98(2)). In all cases 0.04 
M buffer (MES, HEPES, CHES) was used to maintain the pH. The initial concentration of 
NPA varied from 0.9 to 12 mM. The reported kinetic data, determined by the initial slope 
method (≤ 3 % conversion) are averages of duplicate measurements (reproducibility better 
than ± 5%). In a typical experiment, the pH of the solution containing 0.5 mM ligand zinc(II) 
was adjusted to the desired pH value. 1.8 mL of this solution was equilibrated at 298 K in the 
spectrophotometer, then 0.2 mL of freshly prepared 0.02 M pNPA in CH3CN was injected 
into the solution with efficient mixing. The increase of the absorbance at 400 nm was 
immediately followed. The pH of the mixture was checked after every kinetic run. 
 
3. Results and Discussion 
The studied pentadecapeptide L has seven groups able to (de)protonate between pH = 2-11 (2 
Lys, 3 His, 1-1 Glu and Asp). The protonation constants and the corresponding pK values are 
listed in Table 1. pK1 and pK2 belong to the carboxylate groups. The pKs related to the 
imidazole rings (pK3,4,5 = 5.86 – 6.99, Table 1) are in the range generally observed for His-
containing peptides. Since these deprotonations are strongly overlapped, the values in Table 1 
are macroscopic constants and cannot be related to individual histidine residues. Above pH 10 
the deprotonations of the two lysine ε-NH3+ take place, also in an overlapping manner. Due to 
the relatively low peptide concentration applied in our measurements the pK < 3.6 and pK > 
10.4 values have somewhat higher uncertainties than usual for pH-potentiometric studies (see 
also the experimental part).  
 
3.1 Zinc(II) complexes  
In equimolar solution of zinc(II) and L, a series of differently protonated complexes were 
detected between pH 4 and 11. As a consequence of the positively charged N- and C-terminal 
lysine residues, precipitate formation, which is very frequent in presence of zinc(II) and N-
protected peptides [29,30], was not observed. Around pH 7 the diprotonated complex ZnH2L 
is dominant in the solution (Figure 1). This is corroborated with the ESI-MS results (Figure 
2), which indicated the formation of water adduct of these species at m/z 601.3 
([ZnH3L+2H2O]3+) and at m/z 901.4 ([ZnH2L+2H2O]2+). 1H NMR investigations have been 
performed to identify the metal binding sites in the formed complexes. The assignment of the 
proton signals was based on COSY, TOCSY and ROESY experiments. The pH dependence 
of the signals in equimolar solution of zinc(II) and peptide is shown in Figure 3. The shift of 
C2-H and C5-H signals of the imidazole rings upon complex formation, especially at pH 6, 
indicates that the three imidazole rings are coordinated in ZnH2L. The changes of the 1H 
NMR spectra of the peptide at pH 7 upon addition of zinc(II) are depicted in Figure 4. The 
signals of the two terminal lysines do not shift, remain sharp and well resolved, suggesting 
that they are protonated in ZnH2L. However, unexpectedly strong broadening has been 
observed for most amino acid residues, including those containing non-coordinating side 
chains, such as Phe and Gly. This indicates intermediate exchange between the free and 
bound peptide. In addition, the fact that all central residues of the pentadecapeptide are 
affected upon zinc(II) binding, i.e. no freely rotating part of the molecule is present apart the 
terminal lysines, indirectly suggests the coordination of the three histidine side chains, too. On 
the other hand, besides the broadening, the signals related to the two leucine residues are also 
shifted upon complex formation, and their methyl groups become inequivalent in the 
complexes (Figs. 3 and 4). This indicates conformational changes of the peptide during the 
formation of the two macrochelates between the three coordinated imidazole rings.  
The stability constant of ZnH2L (Zn2+ + H2L = ZnH2L, log K1 = 4.46) is somewhat 
lower than those of some {3Nim} coordinated zinc-peptide complexes (log K = 5.09 for Ac-
HVHAH-NH2 [31], log K = 4.64 for Ac-HAAHVVH-NH2 [30]), due to the larger 
macrochelate rings formed between the imidazole rings in the present case. The lower 
stability also suggests that additional coordination of carboxylate groups can be neglected. 
The unsaturated coordination sphere in ZnH2L results in the formation of bis-complex 
(Zn(H2L)2) in the presence of ligand excess. The value of log (K1/K2) = 0.88 indicates 
identical binding of the two ligands in the bis-complex.  
Increasing the pH above 7, the complex ZnH2L releases four additional protons with 
pK = 7.59, 8.60, 10.06 and 10.66, respectively (Table 1, Figure 1). New peaks reflecting slow 
exchange between the free and bound ligand, observed earlier for amide-coordinated zinc(II) 
complexes of Gly-His, Ala-His and Gly-His-Lys [32,33], were not detected on the 1H NMR 
spectra up to pH 8.8 (Figure 3), suggesting that zinc(II) promoted deprotonation of amide 
nitrogen(s) is unlikely. Moreover, the peaks related to 1Lys/15Lys are unchanged upon zinc(II) 
binding, indicating that these residues are still protonated. Consequently, the first two 
deprotonations are related to the formation of mixed hydroxo complexes 
(ZnHL=Zn(H2L)(OH) and ZnL=Zn(H2L)(OH)2), similarly to many other zinc(II)-peptide 
systems [11,16,34]. During the last two processes the deprotonation of the Lys residues take 
place. Indeed, the observed pKs are close to those of the lysine residues in the absence of 
zinc(II) (Table 1).   
Since hydroxamic acids are well known inhibitors of MMPs, operating by 
coordination to the catalytic zinc, we also studied the complex formation in the zinc(II)-L-
benzohydroxamic acid (B) ternary system. The formation constants determined for the binary  
zinc(II)-B complexes (Table 2) are close to those determined earlier [35,36]. Only two ternary 
species can be detected (Zn(H3L)B and Zn(H2L)B), and their sum is slightly higher than those 
of the binary species around the physiological pH (Figure 5). Indeed, the values of ∆logK = 
log βZnHxLB – log βZnHxL – log βZnB = 0.16 (x = 3) and –0.42 (x = 2) indicate enhanced stability 
of the ternary complexes [37], especially considering the crowded environment of zinc(II) 
caused by the large peptide molecule.  
Consequently, the complex ZnH2L mimics some specific features of MMPs’ active 
centers: the peptide is coordinated to zinc(II) by three imidazole nitrogens, the deprotonation 
of the zinc-bound water takes place near to the neutral pH-range (pK = 7.6 and 8.6), and it 
forms relatively stable ternary complexes with hydroxamic acids. Nevertheless, the zinc 
binding affinity of the peptide, probably according to its flexible structure, is very modest in 
comparison with the apo-enzymes. 
 3.2 Copper(II) complexes 
The presence of separated histidines in a peptide chain allow the formation of 
oligonuclear copper(II) complexes, since the imidazole ring is an efficient anchoring group 
for copper(II) promoted amide deprotonation [38]. Consequently, in the copper(II)-L system 
mono-, di- and trinuclear complexes may form. This was confirmed by our ESI-MS data 
(Figure 6), which indicated the formation of mononuclear (e.g. [CuH3L]3+ at m/z = 588.9, 
[CuH
–2L]2– at m/z = 880.9), dinuclear (e.g. [Cu2H–4L]2– at  m/z = 911.3) and trinuclear (e.g. 
[Cu3H–6L]2– at  m/z = 941.8) species. Therefore, the copper(II) binding ability of L has been 
studied by combined pH-metric, UV–Vis, CD, 1H NMR and EPR spectroscopic methods at 
3/1, 2/1, 1/1, and 1/2 [Cu2+]tot/[L]tot ratios. Since the complexes with different nuclearity may 
have several protonation states, the copper(II)-L system presents a complicated, but rather 
obvious speciation behavior. The comparative evaluation of the experimental data indicated 
the formation of 7 mononuclear, 6 dinuclear and 7 trinuclear species (Table 1, Figure 7).  
Below pH 5 two mononuclear complexes CuH4L and CuH3L are formed in a strongly 
overlapping manner (Figure 7), therefore only the spectroscopic parameters of the latter can 
be determined with certainty (λd-dmax ~ 695 nm, g// = 2.285, A// = 160 G, low intensity CD 
spectrum). These data indicate {2Nim} coordination in CuH3L, with the possibility of 
additional carboxylate coordination. Between pH 5-7 the complex CuH2L dominates in the 
solution. Its spectroscopic parameters (λd-dmax ~ 630 nm, g// = 2.260, A// = 173 G, low intensity 
CD spectrum) suggest {3Nim} coordination. This is confirmed by the 1H NMR spectra of the 
peptide detected with increasing concentration of copper(II) (Figure 8). At [Cu2+]/[L] = 0.01 
ratio, only the C2-H and C5-H protons of the three imidazole rings are strongly broadened. 
On the other hand, at [Cu2+]/[L] = 0.09 ratio, only the lysine signals remained relatively well 
resolved (Figure 8). These facts indicate that the central metal ion has {3Nim} type 
coordination in CuH2L, and the two protons are located on the terminal lysine ε-amino 
groups. The log K value for the reaction Cu2+ + H2L = CuH2L (log K = 7.77) agrees well with 
the constants available for {3Nim} coordinated copper(II)-peptide complexes with different 
size of macrochelate rings (log K = 8.08 for Ac-HAHVH-NH2 [31], log K = 7.80 for Ac-
HAAHVVH-NH2 [30], log K = 7.48 Ac-(HNPGYP)3-NH2 [39]). These data also indicate that 
the consideration of additional carboxylate coordination is not necessary to account for the 
observed stability.  
Between pH 6-10 four successive deprotonations have been observed, which result in 
characteristic changes on the UV-Vis, CD and EPR spectra, indicating the increase of the 
ligand-field strength around the metal ion. At pH 8.2 and 9.5 CuL and CuH
–1L are the 
dominant species (Figure 7). Their spectroscopic parameters (λd-dmax ~ 585 and 525 nm, g// = 
2.225 and 2.195, A// = 172 and 190 G, intense CD spectra) indicate {Nim,2N–} and {Nim,3N–} 
type coordination, respectively. The UV-Vis (Table 1), CD (Fig. S2, see Supplementary Data) 
and EPR (Fig. S6) spectra of CuH
–1L and CuH–2L are nearly identical, indicating that the last 
detected deprotonation do not affect the coordination sphere of copper(II). Indeed, the 
observed pK value (10.27) is close to one of the lysine pK in the free peptide (Table 1).  
Although CuH2L has much higher thermodynamic stability than ZnH2L, the amide 
coordination ceases the analogy between the copper(II) binding of L and the recently 
identified copper(II) containing variants of MMPs already at pH 7. 
The side chains of peptide L can not provide high affinity binding for two or three 
copper ions, consequently the oligonuclear complexes are formed by the deprotonation and 
coordination of amide nitrogens. Indeed, in presence of metal ion excess the spectroscopic 
data, especially the intense CD band detected around 280 nm, corresponding to the 
copper(II)-amide charge transfer transition, indicate the coordination of amide nitrogens at 
nearly two units lower pH than observed in the equimolar system (Figure 9). The successive 
formation of the complexes are strongly overlapped (Figure S3), and the presence of several 
binding isomers can be expected in most of the cases, i.e. clear binding site assignment cannot 
be made, although {Nim,N–}, {Nim,2N–}, and {Nim,3N–} coordination environment can be 
expected around the copper(II) ions. All oligonuclear complexes have detectable, but 
unresolved EPR spectra (Figs. S4. and S5), indicating weakly interacting metal ions, as 
expected based on the well separated His units within the peptide chain.  
 
3.3 Kinetic study 
As stated above, the complex ZnH2L mimics some specific features of MMPs’ active centers, 
e.g. the formation of zinc-bound hydroxide ion in the neutral pH-range, which is the key 
feature of zinc promoted hydrolytic processes. Therefore we performed kinetic study to screen 
the hydrolytic activity of the zinc(II)-L system, by using p-nitrophenyl acetate (pNPA), a 
generally used activated substrate. The presented kinetic data were corrected with the 
autohydrolysis of pNPA. The pH - rate constant profile (Figure 1) indicates that important 
hydrolytic activity developed between pH 7 and 9, which can be related to the mono- and 
dihydroxo complexes (ZnHL and ZnL). Indeed, between pH 7.4 and 9.2 the observed kobs,corr 
values can be well reproduced by the equation kobs,corr = kZnHL×[ZnHL] + kZnL× [ZnL] (dashed 
line in Figure 1), where the individual second-order rate constants are kZnHL = 0.24 M–1s–1 and 
kZnL = 1.44 M–1s–1. This is also confirmed by the linear dependence of kobs,corr on the sum of 
ZnHL and ZnL concentrations at pH 9.19 (Figure S7).  Since the deprotonation of ZnL above 
pH 9.2 do not affect the coordination environment of zinc(II), the complexes ZnH
–1L and 
ZnH
–2L are probably also active, but their formation is out of the biologically relevant pH-
range. 
 In order to have better insight into the mechanism, the initial rate of hydrolysis was 
measured as the function of substrate concentration at pH 8.7. As shown in Figure 10, above 
40-fold excess of substrate, saturation was observed. This indicates a fast pre-equilibrium 
related to the formation of the catalytically active (catalyst-substrate) adduct, followed by the 
rate determining transformation of the substrate within this adduct. The treatment of the data 
in Figure 9, using the Michaelis-Menten model, yielded kcat = 0.0090 s–1 and KM = 0.0077 M.  
The zinc-bound hydroxide ion may operate both as direct nucleophile or general base 
catalyst. Although, we are not able to differentiate these processes, in the present case general 
base catalysis seems to be more probable. It is not clear, what is the reason of the six-fold 
lower activity of ZnHL as compared to ZnL, since they may operate in the same way. May be 
the first hydroxide is engaged in a hydrogen bond.  
Despite the frugality of the present peptide model, the observed hydrolytic activity for 
ZnHL and ZnL is somewhat higher then those of other simple enzyme mimicks (Table 2), 
especially considering the pKs of zinc-bound water deprotonation. However, the de novo 
designed hydrolytic metalloenzyme with similar {3Nim,OH–} coordinated catalytic centre [43] 
possesses higher activity, probably due to the higher preorganization of the active site.  
 
4. Conclusions 
The presently studied hexadecapeptide (Ac-KAHEFGHSLGLDHSK-NH2, L) is 
identical with the catalytic zinc(II) binding sequence (197-213) of human MMP-13. This part 
of the protein is tightly engaged within the tertiary structure, while the model peptide is 
virtually unstructured in aqueous solution. As a consequence, its zinc(II) and copper(II) 
binding affinity is rather modest in comparison with the apo-enzymes. Nevertheless, the 
zinc(II)-L system mimics some basic features of the MMP active sites: the main species 
around pH 7 (ZnH2L) possesses {3Nim,H2O} coordination environment, the deprotonation of 
the zinc-bound water takes place near to the physiological pH, it forms relatively stable 
ternary complexes with hydroxamic acids, and the species ZnH2L(OH) and ZnH2L(OH)2 
have notable hydrolytic activity between pH 7-9.  
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 Table 1. Formation constants of the proton, zinc(II) and copper(II) complexes of L (estimated 
errors in parentheses referring to the last digit, I = 0.1 M NaCl, T = 298 K) and the λd-dmax 
value of the copper(II) complexes 
HqLr log βpqr pK HqLr log βpqr pK 
HL 10.9(2) 10.9 H5L 40.20(1) 5.86 
H2L 20.95(8) 10.05 H6L 44.28(4) 4.08 
H3L 27.94(1) 6.99 H7L 47.5(1) 3.2 
H4L 34.34(1) 6.40    
   
   
MpHqLr log βpqr MpHqLr log βpqr MpHqLr log βpqr 
ZnH3L 31.59(4) ZnL 9.22(3) ZnH-2L -11.5(1) 
ZnH2L 25.41(3) ZnH-1L -0.84(3) ZnH4L2 49.94(2) 
ZnHL 17.82(3) 
 
   
 
     
MpHqLr log βpqr λd-dmax (nm) log βpqr MpHqLr λd-dmax (nm) 
CuH4L 38.40(2) - Cu2H–4L -11.61(3) 535 
CuH3L 33.94(1) 695 Cu2H–5L -21.95(10) 525 
CuH2L 28.72(1) 630 Cu2H–6L –32.9(2) 525 
CuHL 21.36(3) 595 Cu3H–2L 10.51(3) 610 
CuL 13.87(3) 585 Cu3H–3L 4.06(2) 610 
CuH
-1L 5.02(3) 525 Cu3H–4L –2.91(2) 595 
CuH
-2L -5.25(4) 525 Cu3H–5L –10.49(2) 570 
Cu2L 19.88(2) - Cu3H–6L –19.37(2) 550 
Cu2H–2L 6.12(2) 590 Cu3H–7L –29.63(3) 540 
Cu2H–3L -2.25(3) 545 Cu3H–8L –39.47(2) 530 
 
 
 
Table 2. Formation constants of the proton and zinc(II) complexes of benzohydroxamic acid 
(B) and its ternary complexes with L (estimated errors in parentheses referring to the last 
digit, I = 0.1 M NaCl, T = 298 K). 
 
MpHqLrBs log βpqrs pK/log K 
HB 8.71(1) pK = 8.71 
MB 4.97(3) log K1 = 4.97 
MB2 9.20(4) log K2 = 4.23 
M(H3L)B 36.72(6) log KZnH3L+B = 4.78 
M(H2L)B 29.96(3) log KZnH2L+B = 4.55 
 
 
Table 3. Kinetic data of selected catalysts for p-nitrophenyl acetate hydrolysis at 25 °C.  
 
Catalyst pKH2O
1
 kcat/KM (M–1s–1) kcomplex  (M–1s–1) Ref. 
Zn(H2L)(OH) 7.59  0.24 this work 
Zn(H2L)(OH)2 8.60 ~ 1.2 (at pH 8.7) 1.44 this work 
Zn[12]aneN3(OH) 7.20  0.041 [40] 
Zn[12]aneN4(OH) 7.90  0.11 [41] 
Zn2A(OH)2 7.80  0.07 [42] 
Zn2A(OH)22 9.80  2.2 [42] 
Zn(Hg(B)3)(OH)3  8.80 17.6 (at pH 9.0)  [43] 
 
1
 pK of zinc-bound water deprotonation 
2A = 2,6,9,12,16-pentaaza-[17](2,9)(1,10)phenanthrolinophane 
3B = Ac-GLKALEEKCKALEEKLKALEEKHKALEEKG-NH2  
Legend 
 
 
Figure 1. Speciation diagram of the zinc(II)-L system  ([Zn2+] = [L] = 0.001 M, T = 298 K, I 
= 0.1 M NaCl) and the pH - kobs,corr profile (□) of the pNPA hydrolysis ([Zn2+] = [L]= 0.00053 
M, [pNPA] = 0.001 M). The dashed line represents the calculated kobs,corr values (see text). 
 
Figure 2: Calculated (upper) and measured (lower) ESI-MS spectra of the [ZnH2L+2H2O]2+ 
(A) and [ZnH3L+2H2O]3+ (B) complexes. 
 
Figure 3: The pH-dependence of the 1H-NMR spectra of L in the presence and absence of 
equimolar zinc(II) ([Zn2+] = [L] = 0.0028 M). 
 
Figure 4: The change of 1H-NMR spectra of L at pH=7.4 upon zinc(II) addition ([L] = 
0.0057 M). 
. 
Figure 5. Calculated competition plot between the zinc(II) complexes of L, B and their 
ternary species ([L] = [Zn2+] = 0.001 M, [B] = 0.002 M) 
 
Figure 6: Calculated (upper) and measured (lower) ESI-MS spectra of [CuH3L]3+ (A), [CuH-
2L]2- (B), [Cu2H-4L]2- (C) and [Cu3H-6L]2-(D) complexes 
 
Figure 7. Speciation diagram of the copper(II)-L system  ([Cu2+] = [L]= 0.001 M, T = 298 K, 
I = 0.1 M NaCl). 
 
Figure 8: The change of 1H-NMR spectra of L at pH = 6.7 upon copper(II) addition ([L] = 
0.0057 M). 
 
Figure 9: pH dependence of the CD intensities at 280 nm of the copper(II) – L systems at 1:1 
(black square, [L] = [Cu2+] = 0.0012 M), 1:2 (grey square, 2[L] = [Cu2+] = 0.0018 M) and 1:3  
(open square, 3[L] = [Cu2+] = 0.0018 M) [Cu2+]/L ratios (T = 298 K). 
 
Figure 10: The initial rate of the catalyzed hydrolysis of pNPA as a function of pNPA 
concentration ([L] = [Zn2+] = 0.00014 M, pH = 8.7, T = 298 K).  
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